Why the study?
How do different antihypertensive agents affect serum lipids and lipoproteins in patients with hypertension?
How do different antihypertensive agents affect serum lipids and lipoproteins in patients with hypertension?
When selecting antihypertensive therapy, clinicians should consider the drug's effect on lipid profiles to avoid worsening other cardiovascular risk factors.
Alerts to lipid effects with some antihypertensives; leaves open net CV benefit versus modern regimens.
Hypertension is a major risk factor for arteriosclerotic vascular disease. Despite intensive antihypertensive intervention, the risk of cardiovascular disease has not declined appreciably. Many of the antihypertensive agents have been shown to elevate total serum cholesterol and triglyceride levels or lower the high-density lipoprotein-cholesterol level. Thus, the antihypertensive agents chosen may negate the beneficial effects of a lower blood pressure. Our purpose is to review all available antihypertensive medications and their influence on lipoprotein metabolism. Choosing the antihypertensive therapy least likely to worsen or precipitate other known cardiovascular risk factors is important. Cost and side effect profiles must also be considered in choosing the best antihypertensive regimen for your patients.
No takes yet. Share an insight, caveat, or question.
Claude K. Lardinois (1988) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: